Summary

Eligibility
for males ages 18 years and up (full criteria)
Location
at San Francisco, California
Dates
study started
estimated completion
Principal Investigator
by Hala Borno, MD
Photo of Hala Borno
Hala Borno

Description

Summary

This clinical trial studies barriers to genetic testing in African American men with prostate cancer and whether tailored, culturally relevant genetic testing education provided by a community-based health coach is beneficial in improving knowledge, attitudes, and awareness of genetic testing. Information gained from this study, may help researchers better understand and learn more about how to increase access to germline genetic testing in underrepresented populations.

Official Title

Navigate Study: Use of a Community-Based Health Coach to Improve Access to Germline Genetic Testing Among African American Men With Prostate Cancer

Details

PRIMARY OBJECTIVE: I. To assess uptake of genetic testing using tailored education strategies and culturally relevant cancer resources delivered by a community-based health coach. SECONDARY OBJECTIVE: I. To assess decisional conflict among African American men receiving tailored education strategies and culturally relevant cancer resources on genetic testing delivered by a community-based health coach. TERTIARY OBJECTIVE: I. To assess the germline mutation rate among African American men with prostate cancer. OUTLINE: Patients are assigned to 1 of 2 cohorts. COHORT A: Patients complete a survey about knowledge of, attitudes towards, and awareness of genetic testing and technology preferences and use over 30 minutes at baseline and over 20 minutes at exit or follow up. Patients may also undergo genetic testing. COHORT B: Patients participate in educational session with health coach over 60 minutes. Patients also complete a survey about knowledge of, attitudes towards, and awareness of genetic testing and technology preferences and use over 30 minutes at baseline and over 20 minutes at exit or follow up. Patients may undergo genetic testing.

Keywords

Prostate Carcinoma Prostatic Neoplasms Educational Intervention Genetic Testing

Eligibility

You can join if…

Open to males ages 18 years and up

  • Age >= 18 years old
  • Speak and read English
  • Have no known cancer risk genetic mutation
  • Self-identify as Black or African American
  • Self-report a diagnosis of regional (lymph node positive), advanced, or metastatic prostate cancer per National Comprehensive Cancer Network (NCCN) guidelines

You CAN'T join if...

  • Prior germline genetic test
  • Age < 18 years old
  • Unable to read or answer forms

Location

  • University of California San Francisco accepting new patients
    San Francisco California 94143 United States

Lead Scientist at UCSF

  • Hala Borno, MD
    Assistant Professor, Medicine. Authored (or co-authored) 73 research publications. Research interests: social determinants of health · cancer health disparities · recruitment science · human-centered design · prostate cancer.

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT04763980
Study Type
Interventional
Last Updated